# A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke

Study · id `cardio:ct-nct04437862` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04437862](<https://clinicaltrials.gov/study/NCT04437862>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04437862

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

## Technical summary

Registry record NCT04437862. Allocation not applicable; no masking; primary purpose treatment. Start 2020-10-27 (actual); primary completion 2023-04-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 121 participants (enrolled count; ClinicalTrials.gov record NCT04437862, source copy `cardio:ctgov-nct04437862-2024-08-09`, retrieved 2026-10-26)
- Started: 2020-10-27 (actual) (ClinicalTrials.gov record NCT04437862, source copy `cardio:ctgov-nct04437862-2024-08-09`, retrieved 2026-10-26)
- Primary completion: 2023-04-21 (actual) (ClinicalTrials.gov record NCT04437862, source copy `cardio:ctgov-nct04437862-2024-08-09`, retrieved 2026-10-26)
- Completion: 2023-08-02 (actual) (ClinicalTrials.gov record NCT04437862, source copy `cardio:ctgov-nct04437862-2024-08-09`, retrieved 2026-10-26)
- Countries: United States; France (ClinicalTrials.gov record NCT04437862, source copy `cardio:ctgov-nct04437862-2024-08-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04437862-2024-08-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
- Acronym: EvaQ
- Condition: Acute Stroke
- Condition: Cerebral Ischemia
- Intervention (Device): Q Revascularization System
- Lead sponsor: MIVI Neuroscience, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 9fcbdd17a920d08cbfba871f0e0249b75b1af550fab14d864a66ea6bf2cf127a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
